There are four primary vital signs: body temperature, blood pressure, pulse (heart rate), and breathing rate (respiratory rate). However, depending on the clinical setting these may include other measurements called the fifth vital sign or sixth vital sign.
Incruse Ellipta: Umeclidinium belongs to the class of medications called long-acting muscarinic antagonists (LAMA). It is used to reduce the symptoms of chronic obstructive pulmonary disease (COPD) including chronic bronchitis and emphysema. Umeclidinium works by relaxing the muscles in the walls of the small airways in the lungs. This allows the airways to open and makes it easier for air to move in and out of the lungs.
DRUG DESCRIPTION. INCRUSE ELLIPTA contains the active ingredient umeclidinium, an anticholinergic. Umeclidinium bromide is a white powder with a molecular weight of 508.5, and the empirical formula is C29H34NO2â¢Br (as a quaternary ammonium bromide compound). It is slightly soluble in water. INCRUSE ELLIPTA is a light grey and light green plastic inhaler containing a double-foil blister strip. Each blister on the strip contains a white powder mix of micronized umeclidinium bromide (74.2 mcg equivalent to 62.5 mcg of umeclidinium), magnesium stearate (75 mcg), and lactose monohydrate (to 12.5 mg).